Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment is a research paper published in Frontiers in Neurology (2023). On theSindex it has a DataRank of 0. It has been cited 71 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30AG062421
National Institutes of Health
Grant: P50AG005134
National Institutes of Health
Grant: RF1AG059856
National Institutes of Health
Grant: U01NS082157
National Institutes of Health
Grant: U01NS100603
National Institutes of Health
Grant: U24AI118663
NINDS NIH HHS
Grant: R01 NS115144
NIA NIH HHS
Grant: P01 AG036694
National Institutes of Health
Grant: 3P50AG005134-04S3
ALZHEIMERS DISEASE RESEARCH CENTER
National Institutes of Health
Grant: 1RF1AG059856-01
CMP3: A CSF Multiple Pathophysiology Panel for Clinical Trials in Alzheimer's Disease
National Institutes of Health
Grant: 5U01NS100603-05
GBA pathway markers for Lewy body dementias
National Institutes of Health
Grant: 5U01NS082157-04
Biomarkers for early intervention in Parkinson disease
National Institutes of Health
Grant: 5U24AI118663-02
Opening a window into immune system signaling at the fg/ml level
National Institutes of Health
Grant: 5P30AG062421-03
Massachusetts Alzheimer's Disease Research Center
Michael J. Fox Foundation for Parkinson's Research
Harvard NeuroDiscovery Center
Fields of Study
Keywords
Sustainable Development Goals